Cargando…
Advantage of First-Line Therapeutic Drug Monitoring-Driven Use of Infliximab for Treating Acute Intestinal and Liver GVHD in Children: A Prospective, Single-Center Study
SIMPLE SUMMARY: Acute GVHD is a common life-threatening complication of allogeneic HSCT and the second most common cause of death in allogeneic HSCT recipients following relapse of the primary disease. Despite advances in GVHD therapy, many patients do not respond sufficiently, and biomarkers to pre...
Autores principales: | Maximova, Natalia, Nisticò, Daniela, Riccio, Guglielmo, Maestro, Alessandra, Barbi, Egidio, Faganel Kotnik, Barbara, Marcuzzi, Annalisa, Rimondi, Erika, Di Paolo, Antonello |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10376946/ https://www.ncbi.nlm.nih.gov/pubmed/37509268 http://dx.doi.org/10.3390/cancers15143605 |
Ejemplares similares
-
P1295: ADVANTAGE OF FIRST-LINE TDM-DRIVEN USE OF INFLIXIMAB FOR TREATING ACUTE INTESTINAL AND LIVER GVHD IN CHILDREN: A PROSPECTIVE, SINGLE-CENTER STUDY.
por: Maximova, Natalia, et al.
Publicado: (2023) -
Defibrotide impact on the acute GVHD disease incidence in pediatric hematopoietic stem cell transplant recipients
por: Squillaci, Domenica, et al.
Publicado: (2023) -
P1272: DEFIBROTIDE IMPACT ON THE ACUTE GRAFT-VERSUS-HOST DISEASE INCIDENCE IN PEDIATRIC HEMATOPOIETIC STEM CELL TRANSPLANT RECIPIENTS.
por: Squillaci, Domenica, et al.
Publicado: (2023) -
Rapid recovery of postnivolumab vemurafenib-induced Drug Rash with Eosinophilia and Systemic Symptoms (DRESS) syndrome after tocilizumab and infliximab administration
por: Maximova, Natalia, et al.
Publicado: (2020) -
Parenteral Nutrition in the Pediatric Oncologic Population: Are There Any Sex Differences?
por: De Nardi, Laura, et al.
Publicado: (2023)